Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: West Pharmaceutical Services | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: West Pharmaceutical Services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

West Pharmaceutical Services

3Q Revenues: $256.2 million (+6%)

3Q Earnings: $13.3 million (+9%)

YTD Revenues: $806.3 million (+6%)

YTD Earnings: $68.3 million (+5%)

Comments: Pharmaceutical systems segment sales were $190.5 million (+10%). Favorable currency translation contributed 4.7% points of that growth. Sales of traditional vial components, metal Flip-off seals, and safety and reconstitution products grew while prefillable syringe component sales declined due to a lower demand for ESA product packaging. Tech Group segment sales were $68.3 million in the quarter (-4%). Sales in 3Q07 included $7.3 million of sales of the discontinued Exubera device and $3.7 million of packaging for an OTC product.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters